BR100 Decreased By (-0.9%)
BR30 Decreased By (-1.08%)
KSE100 Decreased By (-0.81%)
KSE30 Decreased By (-0.88%)
BECO 5.54 Increased By ▲ 0.01 (0.18%)
BML 57.09 Decreased By ▼ -0.86 (-1.48%)
BOP 35.21 Increased By ▲ 0.01 (0.03%)
CNERGY 8.20 Decreased By ▼ -0.02 (-0.24%)
DCL 11.64 No Change ▼ 0.00 (0%)
FCCL 56.49 Decreased By ▼ -0.41 (-0.72%)
FCSC 5.32 Decreased By ▼ -0.07 (-1.3%)
FFL 18.06 Decreased By ▼ -0.07 (-0.39%)
FNEL 1.29 Decreased By ▼ -0.02 (-1.53%)
HUMNL 11.19 Increased By ▲ 0.01 (0.09%)
KEL 8.20 Increased By ▲ 0.05 (0.61%)
KOSM 6.67 Decreased By ▼ -0.29 (-4.17%)
MLCF 100.76 Increased By ▲ 0.24 (0.24%)
NBP 203.00 Decreased By ▼ -0.51 (-0.25%)
PACE 11.49 Increased By ▲ 0.28 (2.5%)
PAEL 43.08 Increased By ▲ 0.33 (0.77%)
PIAHCLA 27.00 Increased By ▲ 0.69 (2.62%)
PIBTL 17.84 Decreased By ▼ -0.10 (-0.56%)
PPL 242.63 Increased By ▲ 0.69 (0.29%)
PRL 35.87 Decreased By ▼ -0.10 (-0.28%)
PTC 65.85 Increased By ▲ 0.27 (0.41%)
SEARL 93.58 Decreased By ▼ -0.82 (-0.87%)
SSGC 32.23 Increased By ▲ 0.91 (2.91%)
TELE 9.11 Increased By ▲ 0.04 (0.44%)
THCCL 66.49 Decreased By ▼ -1.13 (-1.67%)
TPLP 10.95 Increased By ▲ 0.71 (6.93%)
TREET 25.72 Decreased By ▼ -0.12 (-0.46%)
TRG 65.95 Decreased By ▼ -0.73 (-1.09%)
WAVES 11.16 Increased By ▲ 0.11 (1%)
WTL 1.26 Decreased By ▼ -0.03 (-2.33%)
World

Swiss to get Moderna vaccine in tranches until mid-year

  • Switzerland has ordered 15 million vaccine doses in total after setting aside 400 million Swiss francs ($449 million) for shots.
Published January 17, 2021 Updated January 17, 2021 05:23pm
By

ZURICH: Moderna will deliver 7.5 million doses of COVID-19 vaccine to Switzerland in batches in the months ahead, putting the country among the world leaders in inoculating its population, the head of Moderna's European business said.

"We are working at full speed to steadily expand our production capacities. If everything goes as planned, just under half the population could be treated with our vaccine by the summer," Dan Staner told the SonntagsBlick newspaper in an interview.

Staner said Switzerland would not get privileged treatment because it was the first country to chose Moderna as a supplier.

"Every country deserves equal treatment. We refrain from stockpiling vaccines and delivering them only when a country orders them. Every dose that is produced is delivered immediately, according to the contract," he said.

"People are suffering in the same way all over the world. In times like these no one deserves special treatment."

Swiss regulators have approved vaccines from Moderna and from Pfizer with partner BioNTech. They are still reviewing a vaccine from AstraZeneca.

Switzerland, with a population of 8.6 million, has ordered 15 million vaccine doses in total after setting aside 400 million Swiss francs ($449 million) for shots.

Comments

Comments are closed for this article.